IGKV1D-22 and diabetes mellitus: In frail subjects, similar to what has been observed in diabetes, excessive S100A8/A9‐mediated RAGE signaling could contribute to myelopoiesis, leukocytosis, and vascular dysfunction (Flynn et al., 2020; Johnson et al., 2021; Nagareddy et al., 2013).